Replies to post #62548 on Biotech Values

[DewDiligence]

IOMI closed at 6.33 (+116%), a 4% discount to the nominal 6.60 buyout price that consists of cash and stock.

[rt20]

Great board.

I know you have Iomi on your list of biotech buyouts and just noticed this article on Iomai's transcutaneous vaccination technology (now part of Intercell).

http://www.medgadget.com/archives/2009/11/delivery_method_for_iomais_transcutaneous_vaccine.html

I always thought this had great possibilities. Do you know of anyway to invest in it or is it now just a small part of a huge foreign biotech's portfolio that wouldn't be worth the effort?